Don't delay, get your COVID-19 vaccine or booster today!
Getting vaccinated or receiving a booster if you’re already vaccinated is the best thing you can do to help protect yourself, family and friends.
Vaccines.govFDA 2021 Year in Review - Working for You
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Mar 20
Fruit Fresh Up, Inc Recalls Products due to Possible Health Risk
Food & Beverages
Mar 19
T Fresh Company Recalls Enoki Mushrooms Because of Possible Health Risk
Food & Beverages
Mar 19
Continental Mills Recalls Walmart Great Value Buttermilk Pancake & Waffle Mix Due to Possible Foreign Material Contamination
Food & Beverages
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
CDER Continues to Make Rare Diseases a Priority with Drug Approvals and Programming to Speed Therapeutic Development
Over the past decade or so, we have seen an upward trajectory in the percentage of drugs approved to treat rare or “orphan” diseases.
Sharing Experiences in Rare Diseases Together
This year, the U.S. Food and Drug Administration is part of the worldwide community observing Rare Disease Week—February 28th through March 4th.
Innovation and Scientific Collaboration Moved the Generic Drug Program Forward In 2021
2021 was a productive year for the agency’s generic drug program.
Recently Published Guidances
Mar 15
Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products
Biologics
Mar 15
Human Gene Therapy Products Incorporating Human Genome Editing
Biologics
Mar 11
Guidance for Industry: Current Good Manufacturing Practice and Preventive Controls, Foreign Supplier Verification Programs, Intentional Adulteration, and Produce Safety Regulations: Enforcement Policy Regarding Certain Provisions
Food & Beverages